AI blood test for liver cancer validated in two countries
A new neural network-based diagnostic method detects liver cancer at early stages by analyzing DNA fragments in blood. The technique has been successfully validated in two countries, showing promise for early detection and improved patient outcomes.
A novel AI-driven blood test for liver cancer has been validated in two countries, according to TASS. The method uses neural networks to analyze DNA fragments in the blood, allowing the presence of a tumor to be detected at the earliest stages of development. This approach could enable earlier diagnosis and potentially improve survival rates. The test has demonstrated effectiveness in cross-country validation, marking a significant step toward clinical application.
Source: ТАСС —
original